PRODUCTS
APIs and intermediates
No data

No data

  • Ulipristal Actate
  • Ulipristal Actate
  • Ulipristal Actate
  • Ulipristal Actate
  • Ulipristal Actate
Ulipristal Actate
Ulipristal Actate
Ulipristal Actate
Ulipristal Actate
Ulipristal Actate
+

Share

Ulipristal Actate



Summary:

Ulinastatin acetate was developed by HRA pharmaceutical company and its trade name is Ella. It is used for the prevention of pregnancy within 120h after unprotected sexual behavior or known or suspected contraceptive failure. It is a selective progesterone receptor modulator, which mainly plays an emergency contraceptive role by inhibiting ovulation.

CAS:

126784-99-4

Standard:

Enterprise

Purity:


Keywords:

API and Intermediates

  • Product description
  • Product Intro

    Ulinastat acetate is a new oral emergency contraceptive. It is the active chemical component of Ella, a new generation of emergency contraceptive sold in the United States. It can not only be used within 120 hours after unprotected sexual intercourse, but also the efficacy of emergency contraception chemicalbook will not decrease with the delay of medication time. At the same time, it has good safety and tolerance. Compared with levonorgestrel, the most commonly used emergency contraceptive, ulinastatin acetate has wider clinical applicability and has the potential to prevent more accidental pregnancies.

    Function

    Ulinastat acetate is a progesterone agonist / antagonist, and its mechanism is to inhibit or delay ovulation.

    Application

    Application of ulinastat acetate in emergency contraception

Previous page

Next page

Previous page

Next page

Messages

Note: Please provide accurate and detailed information, and our professional staff will contact you as soon as possible!

Recommended products